EKEugene D. Kumelskiy

Eugene D. Kumelskiy

*This is an algorithmically generated author record based on publicly available information.

Eugene D. Kumelskiy has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Relationship of Markers of The Lipid Profile and Endotoxin-Binding Systems Under the Influence of Grape Polyphenols in Postcovid Patients with Bronchial Asthma During the Sanatorium Treatment

    by E. D. Kumelsky, V. A. Beloglazov, L. Sh. Dudchenko, I. A. Yatskov, E. A. Solovyova, I. V. Shulyak, S. N. Belyaeva, E. S. Vanyan, Е. Д. Кумельский, В. А. Белоглазов, et al.

    Relevance . Despite the high effectiveness of spa treatment in patients with bronchial asthma (BA), not all comorbid conditions can be eliminated by this treatment method, which necessitates the search for new methods of influencing various aspects of BA pathogenesis. Goal . To study the effect of grape polyphenols (GP) on the relationship between lipid profile parameters and markers of endotoxin-binding systems in post-COVID patients with BA during sanatorium treatment. Materials and methods . The study involved 105 BA patients treated at the Sechenov Sanatorium (Yalta). Group 1 (n=60) received GP, group 2 (n=45) did not. Body mass index (BMI), lipid profile, and markers of endotoxin-binding systems (BPI, LSB, LPS, sCD14, zonulin) were evaluated. Results . Significant changes in BPI, sCD14, and zonulin levels were observed in both groups during treatment. However, significant dynamics in BMI, HDL, LDL, and triglycerides were noted only in Group 1: BMI decreased from 29.4 kg/m² (23.5-33.9) to 29.0 kg/m² (23.2- 33.1) (p=0.04); HDL increased from 1.4 mmol/L (1.2-1.8) to 1.9 mmol/L (1.4-2.4) (p=0.01); LDL decreased from 3.5 mmol/L (2.7-4.3) to 3.0 mmol/L (2.5-3.4) (p=0.03); TG decreased from 1.1 mmol/L (0.9-1.6) to 0.9 mmol/L (0.7-0.9) (p=0.04). By the end of follow-up, intergroup comparison revealed significant differences in BMI (p=0.04), LDL (p=0.02), triglycerides (p=0.04), and LSB (p=0.03) levels. In Group 1, numerous correlations between lipid profile and endotoxin-binding system markers were identified before and after treatment. Conclusion . The prospects of using GP as an additional tool for correcting metabolic disorders in post-COVID patients with BA during sanatorium treatment have been confirmed.

  • Open Access

    The impact of some non-drug treatments on the state of endotoxin-binding systems and level of systemic inflammation in patients with bronchial asthma in post-COVID period

    by Evgeny D. Kumelsky, Vladimir A. Beloglazov, Igor A. Yatskov, Galina N. Andreeva, Arsen S. Ebubekirov, Saliha E. Khodzhametova, Кумельский Евгений Дмитриевич

    INTRODUCTION: Bronchial asthma (BA) is one most common disease in the world, with complete control not exceeding 50%. A relevant research trend is the search for new methods of achieving control over BA, taking into account personalized approach. AIM: Based on laboratory markers of endotoxin-binding systems and systemic inflammation, to evaluate the effectiveness of magnetic therapy (MT) and ‘dry’ carbon dioxide baths (DCDB) in combination with grape polyphenols (GP) in spa treatment of BA patients with past coronavirus infection. METHODS: Patients (n=75) undergoing spa treatment in the Pulmonology Department of the Sechenov Academic Research Institute of Physical Treatment Methods, Medical Climatology and Rehabilitation, were divided into 3 groups: group 1 (n=25) — patients who additionally received MT and GP concentrate during treatment, group 2 (n=25) — DCDB and GP concentrate, group 3 (n=25) — only standard spa treatment. Before admission and after treatment, blood plasma was collected for analysis for the following markers: C reactive protein (CRP), bactericidal permeability increasing protein (BPI), lipopolysaccharide-binding protein (LBP), lipopolysaccharide, soluble form of CD14 protein (sCD14), zonulin. RESULTS: The CRP level decreased only in group 1 — from 2.93 to 1.93 mg/l (p=0.011). The BPI level increased in all groups: in group 1 — from 65.50 to 70.70 pg/ml (p=0.012), in group 2 — from 57.60 to 95.00 pg/ml (p 0.001), in group 3 — from 64.90 to 88.30 pg/ml (p=0.008). The level of sCD14, which was initially absent in the blood of patients, after spa treatment increased to 1.54 ng/l in group 1 (p=0.003), to 7.20 ng/l (p 0.001) in group 2 and to 6.40 ng/l (p 0.001) in group 3. The level of zonulin increased several-fold in all groups: in group 1 — from 4.94 to 275.60 ng/ml (p 0.001), in group 2 — from 0.20 to 40.70 ng/ml (p 0.001), in group 3 — from 0.90 to 127.50 ng/ml (p=0.002). CONCLUSION: Use of magnetic therapy and ‘dry’ carbon dioxide baths in combination with grape polyphenol concentrate enhances the effectiveness of classic spa treatment in patients with BA with past coronavirus infection: it activates endotoxin-binding systems and inhibits increased intestinal permeability. Magnetic therapy also reduces systemic inflammation.

  • Dynamics of bronchial asthma morbidity in Crimea

    by O. S. Tretyakova, V. A. Beloglazov, E. D. Kumelsky, I. G. Ulchenko, I. A. Yatskov, M. A. Yatsko, A. V. Korzinina, L. N. Emiruseinov

    Aim . To assess the dynamics and age-specific patterns of bronchial asthma (BA) morbidity in the Republic of Crimea from 2017 to 2024. Materials and methods . Data from the official statistical reporting form No. 12 ("Information on the Number of Diseases Registered Among Patients Residing in the Service Area of a Medical Organization") for the years 2017–2024 were analyzed. Regression analysis was used to quantitatively evaluate trends in BA morbidity. Results . Overall BA morbidity increased from 796,570/0000 in 2017 to 936,16 0/0000 in 2024. Primary incidence rose from 37,430/0000 to 53,780/0000 over the same period. Age-specific trends varied: in the post-pandemic period, both overall and primary incidence declined among children and adolescents (0–14 and 15–17 years), whereas a clear increase was observed in adults aged 18–59 and those aged 60+. Regression analysis confirmed a statistically significant annual increase in BA incidence during the study period (β = 355.3 cases per year; p < 0.001). Conclusion . Crimea has demonstrated a consistent upward trend in both overall and primary BA morbidity. Pre-pandemic years showed rising rates across all age groups. During the pandemic, primary incidence continued to increase while overall morbidity remained stable. In the post-pandemic period, incidence rose among adults (>18 years) but declined in those under 18 years of age.

  • The use of grape polyphenols in combination with magnetic therapy in patients with bronchial asthma who have suffered a new coronavirus infection

    by I.A. Yatskov, V.A. Beloglazov, E.D. Kumelsky, D.V. Shaduro, G.N. Andreeva

    Many patients who have suffered from SARS-CoV-2 infection (new coronavirus infection, NCI) face long-term consequences affecting the respiratory, cardiovascular and nervous systems, as well as the appearance of new symptoms that are not characteristic of their previous health condition. Studies indicate that patients who have undergone NCI are at risk of developing thrombotic disorders and problems with the cardiovascular system due to the presence of a low-grade inflammatory process (LGI). In this regard, there is a need to develop new methods and tools, including non-pharmacological approaches, to combat LGI. Objective. To evaluate the effect of grape polyphenols and magnetic therapy on the state of the LGI in patients with asthma who have undergone COVID-19. Material and methods. The study included patients with a verified diagnosis of asthma, as well as a history of NCI and with manifestations of postcovid syndrome living in the Republic of Crimea. Patients (n=50) according to indications, namely the presence of manifestations of postcovid syndrome, were referred for sanatorium treatment to the Department of Pulmonology of the Sechenov Institute in Yalta. The intervention group (n=20), in addition to standard sanatorium treatment, received a concentrate of polyphenols of Fenokor grapes produced by Resfood LLC, as well as a course of low-intensity magnetic therapy (MT) using a low-frequency magnetic therapy unit with frequency control of UMTvp-MADIN Lux (Magnetoturbotron), Russia. The second group was a control group, and consisted of 30 patients who were comparable in gender and age to the experimental group. ELISA kits manufactured by Cloud Clone Corp. were used to determine the level of C-reactive protein (CRP), zonulin, lipopolysaccharide (LPS), sCD14, LPS-binding protein, and bactericidal protein that increases bacterial permeability (BPI). (Wuhan, Hubei, China). Results. In patients of group 1, after a course of sanatorium treatment with the use of polyphenol concentrate and MT, a significant decrease in the level of CRP was revealed (p<0.011). In both groups, a statistically significant increase in the concentration of BPI, sCD14 and zonulin was registered (p0.05). Conclusions. The use of grape polyphenol concentrates in combination with MT helps to reduce the level of C-reactive protein and increase the activity of components of LPS-binding systems in humans during the recovery period after COVID-19. However, sanatorium treatment can contribute to stress and changes in intestinal permeability, which requires additional research to understand its effect on the enterohematic barrier and protection against excessive translocation of bacterial components from the intestine into the blood.

  • Open Access

    Application of dry carbon dioxide baths and magnetotherapy in the treatment of patients during the post COVID period

    by V. A. Beloglazov, D. V. Shaduro, I. A. Yatskov, N. A. Shadchneva, E. D. Kumelsky, T. S. Abibulaev

    Aim. To study the effect of dry carbon dioxide baths (DCB) and magnetotherapy (MT) on quality-oflife indicators, dyspnoea severity, psychological status and systemic inflammation in patients who had recovered from novel coronavirus infection (NCI).Materials and methods. Patients with a history of NCI were divided into two groups. Group 1 (n = 20) received a course of DCB; Group 2 (n = 20) received a course of MT. A control group (n = 20) comprised relatively healthy individuals with no history of NCI (absence of anti-SARS-CoV-2 S-protein IgG at enrolment), matched by sex and age with the study groups. At baseline — all participants — and after treatment — patients in Groups 1 and 2 — completed questionnaires assessing quality of life, anxiety level and severity of respiratory symptoms (SF-36, HADS, mMRC, Borg scale). Blood plasma was collected to determine C-reactive protein (CRP) by ELISA (Cloud Clone Corp., Wuhan, Hubei, China).Results. Post-COVID patients had lower quality-of-life scores and higher levels of anxiety, depression, dyspnoea and exercise intolerance than controls. Both DCB and MT improved quality-of-life scores and reduced anxiety, depression, dyspnoea and exercise-induced symptom burden in post-COVID patients compared with the control group. According to SF-36, mean total quality of life increased by 9.3% in Group 1 and by 4.55% in Group 2. On the HADS scale, anxiety fell by 16.3% and depression by 19.0% in Group 1; by 8.6% and 14.3%, respectively, in Group 2. In Group 1 the mMRC dyspnoea score decreased by 55%, and the Borg score by 50%; in Group 2 by 35% and 22.5%, respectively. DCB also significantly lowered CRP (p < 0.001) from 1.12 [0.42; 1.81] mg/mL before treatment to 0.91 [0.26; 1.57] mg/mL afterwards.Conclusion. Dry carbon dioxide baths and magnetotherapy appear to be promising approaches for mitigating manifestations of post COVID syndrome, but their efficacy should be confirmed in larger studies.

  • Open Access

    Influence of health resort treatment combined with grape polyphenol concentrate on lipid profile and systemic inflammation markers in patients with asthma during the post-COVID period

    by E. D. Kumelsky, V. A. Beloglazov, I. A. Yatskov, G. N. Andreeva, A. R. Sadikov

       Aim. To assess the effect of health resort treatment combined with grape polyphenols on lipid metabolism and systemic inflammation markers in patients with asthma after COVID-19.   Materials and methods. Patients with asthma and a history of COVID-19, undergoing health resort treatment at the I. M. Sechenov Research Institute of Health Resort Studies and Physiotherapy (Yalta), were divided into two groups. Group 1 included 48 patients who, in addition to standard health resort therapy, received a grape polyphenol concentrate. Group 2 comprised 45 patients treated exclusively with standard health resort therapy. Before and after treatment, the following assessments were performed: anthropometry (height, weight, body mass index [BMI]), pulse oximetry (SpO2), spirometry with measurement of forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1), a 6-minute walk test, and blood analyses of C-reactive protein (CRP), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides.   Results. In asthma patients with post-COVID who received grape polyphenol concentrate during health resort treatment, significant changes were observed in BMI, lipid profile, and CRP levels. In Group 1, the mean BMI decreased from 29.4 kg/m2 at admission to 29.0 kg/m2 at discharge (p = 0.04). HDL rose from 1.4 to 1.9 mmol/L (p = 0.01). LDL dropped from 3.5 to3.0 mmol/L (p = 0.03), triglycerides from 1.1 to 0.9 mmol/L (p = 0.04), and CRP from 3.8 to 2.9 mg/L (p = 0.01). No significant changes in lipid profile were observed in Group 2.   Conclusion. Health resort treatment supplemented by grape polyphenol preparations helps correct lipid imbalance and reduce systemic inflammation in patients with asthma who have recovered from COVID-19.

  • Open Access

    Effects of TGF-b Arg25Pro polymorphism on the markers of systemic inflammation, intestinal permeability, and vascular regulation in patients with bronchial asthma during post-COVID period

    by I. A. Yatskov, V. A. Beloglazov, E. S. Ageeva, E. D. Kumelsky, Yu. O. Popenko

    The condition of patients following new coronavirus infection (NCI) is accompanied by a number of pathophysiologic changes that aggravate the course of the patient’s existing pathology, which is especially manifesting by cardiovascular and respiratory disorders. Cardiovascular risk after NCI is increased many-fold as compared to the patients who did not suffer with this infection. A decreased bronchial asthma (BA) control was reported in patients within post-NCI period. Many changes remain latent for a long time without clinical manifestations but increase the risk of adverse events. Earlier laboratory detection of these abnormalities would significantly accelerate clinical decision-making to reduce the likelihood of severe changes in the future. Transforming growth factor-beta (TGF-β) plays role in the regulation and resolution of inflammatory processes. Polymorphism of the gene encoding TGF-β is known to be associated with the development of BA and atopy, development and progression of remote NCI consequences. The aim of the present study was to investigate the effect of TGF-β Arg25Pro polymorphism on laboratory markers of systemic inflammation, intestinal permeability and vascular regulation in patients with BA who underwent NCI. The study included 72 patients with BA including 52 women (72.22%) and 20 males (27.78%), at a mean age of 64.9±6.86 years) who had a history of NCI. All patients underwent testing to determine the genotype of TGF-β Arg25Pro polymorphism by allele-specific polymerase chain reaction (Litech, Russia). Immunoassay kits (Cloud Clone Corp., China) were used to determine plasma concentrations of C-reactive protein (CRP) (mg/L), zonulin (ng/mL), angiotensin-2 (pg/mL), and TGF-β. Patients with AA genotype of TGF-β Arg25Pro polymorphism had higher level of CRP (3.59; 2.95-3.88) mg/l compared to PP genotypes (1.91; 0.54-3.37) mg/l (p1-2 = 0.028) and AP (2.45; 0.48-2.88) mg/l (p1-3 = 0.005). Plasma zonulin levels were also higher in the group with AA genotype, compared to study groups 2 and 3 (p1-2 = 0.023 and p1-3 = 0.032). The group with AA genotype displayed higher TGF-β levels compared to PP genotype (p1-2 = 0.009). The lowest angiotensin-2 concentration was found in group 1. Conclusion: TGF-β Arg25Pro polymorphism may be associated with development of systemic inflammation and increased intestinal permeability in patients with BA over the post-COVID period.

  • The Effect of Grape Polyphenol Concentrate on Endotoxinemia and Lipid Profile in Patients with Type 1 Diabetes Mellitus

    by I.A. Yatskov, Russian Federation Simferopol, V.A. Beloglazov, E.S. Ageeva, I.N. Repinskaya, E.D. Kumelsky, D.I. Ulyanova

    Aim. To evaluate the effect of grape polyphenol concentrate on the state of lipopolysaccharide-binding systems, lipid profile, levels of circulating lipopolysaccharide (LPS) and markers of inflammation in patients with type 1 diabetes mellitus. Design. Analytical comparative mixed sample controlled retrospective pilot study. Materials and methods. The study included 58 patients with a verified diagnosis of type 1 diabetes mellitus. Participants in the intervention group (n = 30), in addition to basic bolus insulin therapy, received grape polyphenol concentrate 1 teaspoon per day with meals for 4 weeks. However, during the study, 4 patients had side effects associated with taking polyphenol concentrate, which caused them to be excluded from the experiment. In this regard, data from 26 patients of the 1st group will be presented. The control group consisted of 28 patients with a verified diagnosis of type 1 diabetes mellitus, who were comparable in gender and age to patients in the experimental group. In the patients of the experimental group, before and after the application of grape polyphenol concentrate, and in the participants of the control group, 30 days after the start of the study, biological material (blood plasma) was taken for further enzyme immunoassay (ELISA). ELISA kits manufactured by Cloud-Clone Corp. were used to determine the levels of C-reactive protein (CRP), interleukin 6, zonulin, LPS, lipopolysaccharide-binding protein (LBP), and low-density lipoproteins (LDL), including apolipoprotein B-100 (apoB-100). Results. Statistically significant decreases in CRP levels were recorded in the intervention group (from 2.73 (2.32–3.09) to 2.13 (0.94–2.39) mg/l, p = 0.002), LDL (from 3.4 (2.2–5.89) to 2.32 (1.87–2.83) mmol/L, p = 0.028) and apoB-100 (from 2.65 (2.35–2.8) to 2.29 (2.1–2.6) g/l, p = 0.023), an increase in the content of LBP (from 6.1 (5.45–8.62) to 9.18 (8.2–13.19) mg/l, p = 0.002). No significant changes were detected in the control group. Conclusions. A 30-day course of grape polyphenol concentrate in addition to insulin therapy in patients with type 1 diabetes mellitus gives significant positive effects — a decrease in systemic inflammation (in terms of CRP) and an improvement in the lipid profile (a decrease in LDL and apoB-100 concentrations). An increase in the level of LBP indicates the activation of bacterial endotoxin binding and detoxification systems, although a significant decrease in the level of circulating LPS was not achieved in a short period of observation. Keywords: type 1 diabetes mellitus, polyphenols, endotoxin, lipopolysaccharide, inflammation, lipid profile

  • Open Access

    Clinical and Laboratory Characteristics of Patients with Bronchial Asthma who Suffered from COVID-19

    by L.SH. Dudchenko, Russian Federation Yalta, V.A. Beloglazov, E.D. Kumelsky, I.A. Yatskov

    Aim. To identify differences in the clinical and laboratory profile of patients with bronchial asthma (BA) who suffered a clinically significant coronavirus infection caused by the SARS-Cov2 virus and patients with asthma, without anamnestic indications for COVID-19 in the Republic of Crimea. Design. Analytical comparative mixed sample controlled pilot study. Materials and methods. Patients (n = 67) underwent sanatorium-resort treatment in the Department of Pulmonology of the I.M. Sechenov Academic Research Institute in Yalta. Participants were divided into 2 groups: group 1 included patients with asthma and a history of clinically significant COVID-19, and group 2 included patients with asthma without a confirmed history of COVID-19. Before and after treatment, patients underwent a survey assessing the frequency and intensity of coughing, frequency of exacerbations, and severity of shortness of breath, Modified Medical Research Council scale, physical examination assessing the severity of dry wheezing, respiratory rate, and heart rate, an Asthma Quality of Life Questionnaire survey, and a 6-minute walking test. Pulse oximetry, tonometry and spirometry were performed. Biological material was collected: blood plasma for further laboratory analysis, which included the leukocyte formula, erythrocyte sedimentation rate, total cholesterol rate, high-density and low-density lipoproteins, triglycerides (TG) rate and C-reactive protein (CRP) rate. Results. In patients of group 1, the activity limitation index (AQLQ A) was significantly lower than in group 2: 3.82 versus 4.36 points (p = 0.015). Significant differences in the degree of environmental influence on the course of the disease (AQLQ S criterion) were also revealed: in patients of group 1, the index was 3.25 points, and in group 2 — 4.25 points (p = 0.043). TG and CRP levels were higher in group 1 than in group 2: 1.1 versus 0.8 mmol/l (p = 0.04) and 4.0 versus 3.0 mg/l (p = 0.03), respectively. Conclusion. Patients with bronchial asthma who have had COVID-19 show a decrease in quality of life according to the AQLQ A (activity limitation) and AQLQ S (influence of environmental factors on symptoms) criteria, and increased levels of lipid profile markers (TG) and systemic inflammation (CRP), which dictates the need to search for new methods to correct these disorders in such patients. Keywords: bronchial asthma, COVID-19, sanatorium treatment, systemic inflammation.

  • Open Access

    Current Prevalence of Substance Use Disorders and Its Dynamics in the Republic of Crimea: A Retrospective Study

    by Vladislav V. Tkach, Olga S. Tretiakova, Eugene D. Kumelskiy, Anton V. Tkach, Danila A. Kotov

    Introduction: The study of the prevalence of narcological disorders is an integral part of the monitoring of the drug situation allowing identification of the main trends in the situation with the use of narcotic drugs. Objective: To analyze the level and structure of non-medical use of prescription drugs among the population of the Republic of Crimea and to assess their dynamics in 2020–2021. Materials and methods: The subject of the study was quantitative indicators characterizing the spread of drug use disorders in the Republic of Crimea. The information base of the study included data and materials of the Federal State Statistics Service and the Ministry of Health of the Republic of Crimea. We processed data of the statistical reporting documentation for 2020–2021, Forms No. 37, Information on patients with alcoholism, drug addiction, substance abuse, and No. 11, Incidence of substance use disorders. Incidence and prevalence rates were estimated per 100 thousand population. The data were analyzed in Microsoft Excel. Results: We established an increase in the incidence of substance use disorders in the Republic of Crimea in 2020–2021 from 38.3 to 42.9 per 100 thousand population (by 12.01 % in the year 2021 compared to 2020) and an increase in the overall incidence of drug addiction and abuse from 566.5 to 578.3 per 100 thousand population (2.08 %). We noted a slight decrease in opium addiction, transition to new synthetic drugs, and an increase in the proportion of a combined use of narcotic drugs. Males aged 20 to 59 years predominate among drug users. Conclusions: Our findings show a consistently high prevalence of non-medical use of prescription drugs among the population in the Republic of Crimea, an increase in the incidence and prevalence of drug addiction and in the number of doctor’s visits among drug abusers, and a growth of drug overdose deaths.